| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 128.66▲ | 129.06▼ | 129.08▼ | 129.69▼ | 128.53▲ |
| MA10 | 128.70▼ | 129.25▼ | 128.98▼ | 129.43▼ | 130.49▼ |
| MA20 | 129.02▼ | 129.09▼ | 130.09▼ | 129.67▼ | 137.12▼ |
| MA50 | 129.27▼ | 130.60▼ | 129.32▼ | 132.05▼ | 134.01▼ |
| MA100 | 129.16▼ | 129.35▼ | 129.48▼ | 138.72▼ | 131.25▼ |
| MA200 | 130.08▼ | 129.54▼ | 129.79▼ | 137.09▼ | 121.59▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.039▼ | 0.020▲ | -0.173▼ | 0.203▲ | -1.396▼ |
| RSI | 40.401▼ | 39.527▼ | 41.580▼ | 45.976▼ | 44.275▼ |
| STOCH | 21.361 | 35.026 | 45.504 | 49.823 | 32.951 |
| WILL %R | -83.471▼ | -68.780 | -87.097▼ | -54.534 | -71.837 |
| CCI | -52.687 | -142.337▼ | -99.816 | -35.963 | -64.365 |
|
Friday, March 27, 2026 08:01 AM
Neurocrine Biosciences introduces updated clinical guidance targeting tardive dyskinesia management in older care populations. New clinical findings from KINECT PRO reinforce therapeutic outcomes.
|
|
Thursday, March 26, 2026 08:27 AM
Neurocrine Biosciences (NASDAQ:NBIX) on Thursday announced new expert consensus recommendations aimed at improving the screening, diagnosis and treatment of tardive dyskinesia (TD) among older adults ...
|
|
Tuesday, March 10, 2026 04:09 AM
Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International stock ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 30/03/26 | 128.89 | 130.10 | 128.20 | 128.72 | 725,647 |
| 27/03/26 | 132.07 | 132.9525 | 128.05 | 128.32 | 753,480 |
| 26/03/26 | 131.13 | 133.01 | 129.96 | 132.42 | 574,587 |
| 25/03/26 | 128.98 | 133.05 | 128.98 | 131.13 | 1,099,200 |
| 24/03/26 | 126.14 | 128.31 | 125.11 | 127.86 | 1,007,922 |
| 23/03/26 | 129.65 | 130.96 | 127.03 | 127.05 | 696,386 |
| 20/03/26 | 128.83 | 130.16 | 126.68 | 127.68 | 1,918,629 |
| 19/03/26 | 130.62 | 132.25 | 127.07 | 129.70 | 873,726 |
| 18/03/26 | 129.95 | 131.05 | 129.01 | 130.71 | 753,770 |
| 17/03/26 | 130.14 | 131.69 | 129.88 | 130.71 | 632,195 |
|
|
||||
|
|
||||
|
|